Status:

UNKNOWN

Decrease Artery Occlusion by Distal Radial Arterial Cannulation in ACS Patients

Lead Sponsor:

Shenzhen People's Hospital

Conditions:

Acute Coronary Syndrome

Procedural Complication

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

The site of arterial access for coronary angiography and intervention has been the focus of research for decades as it is the source of major complications. Transradial access (TRA) reduces complicati...

Eligibility Criteria

Inclusion

  • presence of a pulse in the snuffbox

Exclusion

  • Absence of pulse
  • Ultrasound indication of arterial occlusion or severe calcification
  • Severe forearm artery malformation
  • Patients with severe liver and renal failure, or abnormal coagulation function
  • Established cardiogenic shock
  • History of previous coronary artery bypass grafting and radial artery use.
  • Raynaud's disease in the medical history

Key Trial Info

Start Date :

March 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2024

Estimated Enrollment :

1500 Patients enrolled

Trial Details

Trial ID

NCT05255939

Start Date

March 1 2022

End Date

February 1 2024

Last Update

February 25 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shenzhen People's hospital

Shenzhen, Guangdong, China, 518000